Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Interaction Map Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX
Showing element 2201 to 2250 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12b isoform a; myosin phosphatase regulatory subunit; myosin phosphatase, target subunit 2. [source:refseq;acc:nm\_002481]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6269.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5846.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0723\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
490\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13346.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15274.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14445\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
18\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
22\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
20\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
22440.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
27642.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
527\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5438.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4775.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase inhibitor 2 (ipp-2). [source:swissprot;acc:p41236]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
313\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
18098.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21644.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1959\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5712.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5608.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog (sui1iso1). [source:swissprot;acc:p41567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2023\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3364.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3560.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3360.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3559.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23a (sec23-related protein a). [source:swissprot;acc:q15436]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3135\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23b (sec23-related protein b). [source:swissprot;acc:q15437]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3127\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24a (sec24-related protein a) (fragment). [source:swissprot;acc:o95486]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3056\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24b (sec24-related protein b). [source:swissprot;acc:o95487]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2956\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2910\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24d (sec24-related protein d). [source:swissprot;acc:o94855]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2903\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 1 (sec61 alpha- 1). [source:swissprot;acc:p38378]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3423.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3614.91\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 2 (sec61 alpha- 2). [source:swissprot;acc:q9y2r3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2078\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 gamma subunit. [source:swissprot;acc:p38384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2265\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3453.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3612.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04606\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6833.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6376.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase beta precursor (ec 3.1.3.48) (r-ptp- beta). [source:swissprot;acc:p23467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
538\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1247\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6807.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6278.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 11 (ec 3.1.3.48) (protein-tyrosine phosphatase 2c) (ptp-2c) (ptp-1d) (sh-ptp3) (sh- ptp2) (shp-2). [source:swissprot;acc:q06124]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2789\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6803.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6275.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08415\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
83\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fer (ec 2.7.1.112) (p94-fer) (c-fer). [source:swissprot;acc:p16591]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1649\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6503.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6079.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06973\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fes/fps (ec 2.7.1.112) (c-fes). [source:swissprot;acc:p07332]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1645\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
255\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
254\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
250\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2838\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoheme ix farnesyltransferase, mitochondrial precursor (ec 2.5.1.-) (heme o synthase). [source:swissprot;acc:q12887]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
933\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoporphyrinogen oxidase (ec 1.3.3.4) (ppo). [source:swissprot;acc:p50336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2934\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2707\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5869.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5450.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
puromycin-sensitive aminopeptidase (ec 3.4.11.-) (psa). [source:swissprot;acc:p55786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
828\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6354.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5745.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2747\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4702.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4708.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative acyl-coa thioester hydrolase cgi-16 (ec 3.1.2.-). [source:swissprot;acc:q9y305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
626\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 3 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:q96hn2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
628\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/